Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex iss... Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy. Show more
SHELTON, CT -- May 2, 2024 -- InvestorsHub NewsWire -- NanoViricides, Inc. (NYSE Amer: NNVC) (the "Company"), a global leader in broad-spectrum antiviral...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -4.05405405405 | 1.48 | 1.6 | 1.33 | 236675 | 1.45827278 | CS |
4 | -0.11 | -7.18954248366 | 1.53 | 1.745 | 1.33 | 159845 | 1.48450317 | CS |
12 | -0.41 | -22.4043715847 | 1.83 | 2.55 | 1.33 | 241031 | 1.91546229 | CS |
26 | 0.08 | 5.97014925373 | 1.34 | 3.59 | 1.0297 | 257311 | 2.03235973 | CS |
52 | 0.12 | 9.23076923077 | 1.3 | 3.59 | 1 | 149608 | 1.91846666 | CS |
156 | -2.99 | -67.8004535147 | 4.41 | 5.56 | 1 | 142676 | 2.71781205 | CS |
260 | -0.38 | -21.1111111111 | 1.8 | 19.8 | 1 | 702689 | 7.05416326 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales